WATERTOWN, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
BANGALORE, INDIA: In-memory database systems (IMDSs) store records in main memory, they never go to disk. Through this elimination of disk access, IMDSs claim significant performance gains over more ...
WATERTOWN, Mass., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
Disc Medicine, Inc. announced it will present data from its hematology portfolio at the European Hematology Association (EHA) 2025 Congress in Milan from June 12-15, 2025. The presentations will ...
Disc Medicine (IRON) shares are having a fantastic year so far. The stock has risen in value by >165%, and is currently priced at $47, valuing the company at $934m at the time of writing. The ...